Trilogy Capital’s Exelon EXC Stock Holding History

Trilogy Capital’s Portfolio EXC Stock Details EXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-6,051	Closed	-$216K	–	119
2019 Q1	$216K	Sell	6,051 -25,975	-81%	-$884K	0.03%	113
2018 Q4	$1.03M	Sell	32,026 -3,801	-11%	-$122K	0.14%	58
2018 Q3	$1.12M	Sell	35,827 -4,912	-12%	-$151K	0.14%	55
2018 Q2	$1.24M	Sell	40,739 -2,559	-6%	-$73.3K	0.17%	40
2018 Q1	$1.21M	Buy	43,298 +23,018	+114%	+$622K	0.17%	44
2017 Q4	$570K	Buy	+20,280	New	+$583K	0.09%	67

Other funds holding EXC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Trilogy Capital's EXC Position: Q2 2019 in Review

Trilogy Capital sold out of Exelon (EXC) in Q2 2019, closing a stake of 6,051 shares — an estimated $216K sold.

Trilogy Capital first reported a position in EXC in Q4 2017 and held it in 6 quarters. The position peaked at $1.24M in Q2 2018. 1,003 funds tracked by Wall St. Rank hold EXC as of Q2 2019.

Trilogy Capital reported no remaining Exelon position as of Q2 2019 after selling out during the quarter.
Trilogy Capital sold 6,051 Exelon shares in Q2 2019, an estimated $216K.
Trilogy Capital first reported a position in Exelon in Q4 2017 and held it in 6 quarters.
Trilogy Capital's Exelon position peaked at $1.24M in Q2 2018.
1,003 funds tracked by Wall St. Rank held Exelon as of Q2 2019.

Based on Trilogy Capital's 13F filing for Q2 2019, filed 11 Jul 2019.